Table 5 Summary of on-treatment AEs in the immuno-PET study (safety population)
Preferred term | Patients, n (%) N = 2 | AEs, n N = 2 | Drug-related AEs, n (%) N = 2 |
|---|---|---|---|
Any AE | 2 (100) | 8 | 2 (100) |
Headache | 2 (100) | 2 | 1 (50) |
Dactylitis | 1 (50) | 1 | 1 (50) |
Diarrhoea | 1 (50) | 1 | 0 |
Dry eye | 1 (50) | 1 | 0 |
Injection-site bruising | 1 (50) | 1 | 1 (50) |
Restless legs syndrome | 1 (50) | 1 | 0 |
Urticarial vasculitis | 1 (50) | 1 | 1 (50) |